Takeda exec not interested in generics; API supplier Perrigo tumbles on Temodar ruling;

@FiercePharma: Pharma's Top 10 Blockbuster Drugs. Report | Follow @FiercePharma

> Japan's Takeda Pharmaceutical is not eager to expand into the generic drug market, the company's president said on the sidelines of the G20 business summit in Seoul. Story

> Perrigo stock tumbled the most in more than 19 months after Merck's Schering-Plough unit won a court ruling on its brain-cancer drug Temodar, because Perrigo is set to supply the drug's active ingredient to generics maker Teva Pharmaceutical Industries. Article

> Drug and food maker Otsuka Holdings' planned listing on the Tokyo Stock Exchange, which will likely be one of the largest listings in Japan this year, is set to be approved by the exchange as early as Friday. Report

> The U.K.'s cost-effectiveness watchdog became more restrictive in its assessment of new cancer drugs between 2007 and 2009, a new report suggests. Item

> GlaxoSmithKline failed to properly warn consumers that its antidepressant drug Paxil could cause birth defects, a lawyer for the family of an injured teenager told jurors. Report

> Workers at pharmaceuticals giant AstraZeneca are to resume strike action in a long-running row over pensions after union talks with bosses collapsed. News

> Danish biopharma Genmab says a planned sale of its U.S. manufacturing plant had been delayed into 2011 as it posted slimmer operating losses for the first nine months of the year. Story

Biotech News

 @FierceBiotech: High-profile banker predicts the end of the Big Biotech era. News | Follow @FierceBiotech

 @JohnCFierce: With patents expiring and innovation rare, cancer drug sales rose 3.5% in 1st 9 months in "unprecedented slowdown." Report | Follow @JohnCFierce

> Biotechs line up to announce an avalanche of QTDP grants. Story 

> Merck ready to spotlight potential mega-blockbuster. Report

> Repros shares slide after FDA advises new Androxal study. News 

> GSK: Expect more M&A deals and new collaborative enterprises. Article 

Drug Delivery News

> Monosol Rx sues competitors over thin-film patent. Report 

> What do nanoparticles do in lungs? Depends on how they're treated. News 

> Microcatheters, mannitol break through BBB. Story 

> Marina Biotech raises $3.3 million. Article 

> Nanoparticle gut check could help colon cancer, Crohn's. Item 

> Feds help small drug companies. Story 

Medical Device News

> Boston Sci implants first Vercise device in Parkinson's study. Story 

> Smith & Nephew reports Q3 results, gets rebuffed in whistleblower suit. Item 

> Chinese researchers warn of phthalates in auxiliary devices. News

> Vascular Pathways names new CEO and location. Report

> Groth resigns as Bioheart CEO. News

> Edwards Lifesciences subpoenaed for heart monitor. Article

And Finally... Pfizer and Boehringer Ingelheim have mobilized a soap opera star, painted rugby players and fielded a special "breathing bus" for a U.K. COPD disease awareness pilot. Report

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.